Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study assesses the effects of twice-daily subcutaneous injection exenatide versus
treatment with sulfonylurea (glimepiride) on long-term glycemic control and beta-cell
function.